Kim, Yong-Mo <br/><br/>
Novel AGLP-1 albumin fusion protein as a long-lasting agent for type 2 diabetes.  [electronic resource] 

 -  BMB reports  Dec 2013 
 - 606-10 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1976-670X 
<br/><br/><label>Standard No.: </label>10.5483/bmbrep.2013.46.12.106  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alanine--genetics<br/>Animals<br/>Blood Glucose--analysis<br/>CHO Cells<br/>Cell Line, Tumor<br/>Cricetinae<br/>Cricetulus<br/>Diabetes Mellitus, Type 2--metabolism<br/>Dipeptidyl Peptidase 4--metabolism<br/>Glucagon-Like Peptide 1--genetics<br/>Glucose Tolerance Test<br/>Half-Life<br/>Humans<br/>Hypoglycemic Agents--metabolism<br/>Mice<br/>Mice, Inbred C57BL<br/>Rats<br/>Recombinant Fusion Proteins--biosynthesis<br/>Serum Albumin--genetics<br/>Transfection